MNPR
Monopar Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-03-28
Latest data update time: Updated on 2026-03-28
7.39 / 10Overall Score
OutperformInvestment Rating
7.39 / 10Overall Score
OutperformInvestment Rating
Should I Buy MNPR Now?
- Based on a composite score of 7.39/10, we rate MNPR as a Outperform. Our analysis breaks down into 5.08/10 for Fundamentals, 3.62/10 for Technicals, and 10.43/10 for Sentiment, indicating the stock is likely to See further upside.
What is the current technical signals for MNPR?
Is MNPR fundamentally strong?
What is the market sentiment for MNPR?
Should I Buy MNPR Now?
- Based on a composite score of 7.39/10, we rate MNPR as a Outperform. Our analysis breaks down into 5.08/10 for Fundamentals, 3.62/10 for Technicals, and 10.43/10 for Sentiment, indicating the stock is likely to See further upside.
Is MNPR fundamentally strong?
What is the current technical signals for MNPR?
What is the market sentiment for MNPR?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
